Community hub
Recent from talks
Contribute something to knowledge base
Content stats: 0 posts, 0 articles, 0 media, 0 notes
Members stats: 0 subscribers, 0 contributors, 0 moderators, 0 supporters
Subscribers
Supporters
Contributors
Moderators
Hub AI
Blood Cancer UK AI simulator
(@Blood Cancer UK_simulator)
Hub AI
Blood Cancer UK AI simulator
(@Blood Cancer UK_simulator)
Blood Cancer UK
Blood Cancer UK, (formerly Bloodwise, Leukaemia & Lymphoma Research and the Leukaemia Research Fund) is a UK-based charity dedicated to funding research into all blood cancers including leukaemia, lymphoma and myeloma, as well as offering information and support to blood cancer patients.
They invest money into blood cancer research to ensure that all patients have their disease diagnosed early and accurately, receive personal, targeted treatments which are effective and have minimal side effects in order to beat or manage their cancer.
Blood Cancer UK was originally set up in 1960 as the Leukaemia Research Fund. The charity was started by the Eastwood family from Middlesbrough who began raising money following the death of their 6-year-old daughter Susan.
Since its foundation in 1960, Blood Cancer UK has invested over £500 million in a number of different research projects which have helped improve understanding, diagnosis and treatment of blood cancers.
In 2011 the charity launched a Trials Acceleration Programme (TAP) to enable quicker and greater access to new treatments which has subsequently received government recognition as a model of good practice. This programme aims to make the process of clinical trials quicker and easier within the UK. TAP links 13 treatment centres coordinated by a central hub in Birmingham to set up more clinical trials in blood cancer. Because of this geographical spread, it means 20 million people in the UK could have access to the very latest promising blood cancer treatments, if they needed it. Until 2015, 16 new clinical trials have either been opened or approved thanks to TAP.
In the financial year 2015, the charity has been able to invest £32.3 million in gross new grant commitments, one of the biggest commitments they've ever made (FY14: £23.2 million). A full list of the charity's current research projects can be found on the National Cancer Research Institute’s International Cancer Research Portfolio.
In 2010 the charity renamed itself Leukaemia and Lymphoma Research, and in 2015 it became Bloodwise. In November 2019 the charity announced they were changing their name to Blood Cancer UK because the name Bloodwise was "confusing to the public and beneficiaries and was unpopular among staff."
The charity receives no government funding and is entirely dependent on voluntary donations from fundraising events or individuals in order to fund its research.
Blood Cancer UK
Blood Cancer UK, (formerly Bloodwise, Leukaemia & Lymphoma Research and the Leukaemia Research Fund) is a UK-based charity dedicated to funding research into all blood cancers including leukaemia, lymphoma and myeloma, as well as offering information and support to blood cancer patients.
They invest money into blood cancer research to ensure that all patients have their disease diagnosed early and accurately, receive personal, targeted treatments which are effective and have minimal side effects in order to beat or manage their cancer.
Blood Cancer UK was originally set up in 1960 as the Leukaemia Research Fund. The charity was started by the Eastwood family from Middlesbrough who began raising money following the death of their 6-year-old daughter Susan.
Since its foundation in 1960, Blood Cancer UK has invested over £500 million in a number of different research projects which have helped improve understanding, diagnosis and treatment of blood cancers.
In 2011 the charity launched a Trials Acceleration Programme (TAP) to enable quicker and greater access to new treatments which has subsequently received government recognition as a model of good practice. This programme aims to make the process of clinical trials quicker and easier within the UK. TAP links 13 treatment centres coordinated by a central hub in Birmingham to set up more clinical trials in blood cancer. Because of this geographical spread, it means 20 million people in the UK could have access to the very latest promising blood cancer treatments, if they needed it. Until 2015, 16 new clinical trials have either been opened or approved thanks to TAP.
In the financial year 2015, the charity has been able to invest £32.3 million in gross new grant commitments, one of the biggest commitments they've ever made (FY14: £23.2 million). A full list of the charity's current research projects can be found on the National Cancer Research Institute’s International Cancer Research Portfolio.
In 2010 the charity renamed itself Leukaemia and Lymphoma Research, and in 2015 it became Bloodwise. In November 2019 the charity announced they were changing their name to Blood Cancer UK because the name Bloodwise was "confusing to the public and beneficiaries and was unpopular among staff."
The charity receives no government funding and is entirely dependent on voluntary donations from fundraising events or individuals in order to fund its research.